Tag Archives: intellectual property

Supreme Court Reverses In Caraco Appeal

Today, in Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk, in an opinion authored by Justice Kagan (a copy can be found at the end of this post), the Court reversed the Fed. Cir.’s divided 2010 decision that an ANDA filer … Continue reading

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , , , | 1 Comment

Mayo v. Prometheus – A European View

A Guest Post from Paul Cole, European Patent Attorney, Lucas & Co; Professor of IP law, Bournemouth University. Is a claim to an assay patent-eligible when all its features are known save for how it should be interpreted? The interpretation … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 3 Comments

Supreme Court Remands In Myriad Appeal

Today, as predicted by many commentators, the Supreme Court set aside the ruling by the Fed. Cir. that claims to isolated DNA sequences that are the BRCA 1 or 2 gene, or fragments thereof, are patentable subject matter. The Supreme … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 1 Comment

“Handbook of Quality Procedures Before the EPO”

The ECP, epi and Business Europe have collaborated to produce a downloadable, fifty page guide to practice before the EPO. While not binding on Examiners, it was issued under the authority of the EPO and is a sort of mini-MPEP, … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , , , | Leave a comment